LNA Santé Stock price

Equities

LNA

FR0004170017

Healthcare Facilities & Services

Market Closed - Euronext Paris 12:35:06 2024-03-28 pm EDT 5-day change 1st Jan Change
20.45 EUR -3.99% Intraday chart for LNA Santé -3.76% +1.74%
Sales 2023 736M 794M Sales 2024 * - Capitalization 209M 226M
Net income 2023 23M 24.82M Net income 2024 * - EV / Sales 2023 0.28 x
Net Debt 2023 * 806M 870M Net cash position 2024 * - 0 EV / Sales 2024 * -
P/E ratio 2023
8.78 x
P/E ratio 2024 *
-
Employees 7,759
Yield 2023 *
2.09%
Yield 2024 *
-
Free-Float 47.17%
More Fundamentals * Assessed data
Dynamic Chart
LNA Santé: 9% drop in annual RNPG CF
LNA Santé: LNA Ensemble exceeds 10% of voting rights CF
LNA Santé: sales up 1.1% in 2023 CF
LNA Santé SA(ENXTPA:LNA) dropped from S&P Global BMI Index CI
LNA Santé SA Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Alphabet and Microsoft neutralize each other Our Logo
LNA Santé SA Reports Earnings Results for the Full Year Ended December 31, 2022 CI
LNA Santé SA's Equity Buyback announced on February 3, 2022, has expired. CI
LNA Santé SA Reports Earnings Results for the Half Year Ended June 30, 2022 CI
An unknown buyer acquired minority stake in LNA Santé SA from Mérieux Participations 2, SAS managed by Mérieux Développement SAS. CI
LNA Santé SA Reports Earnings Results for the Full Year Ended December 31, 2021 CI
LNA Santé SA to Seek Acquisitions CI
LNA Santé SA commences an Equity Buyback Plan for 970,593 shares, representing 10% for €97.06 million, under the authorization approved on June 23, 2021. CI
LNA Santé SA announced that it has received funding from Groupe Siparex, Unexo, SCR, Sodero Gestion, BNP Paribas Développement SA, SCR, SMA Group Limited, Financiere Vertavienne 44 CI
LNA Santé SA announced that it expects to receive funding from Groupe Siparex, Unexo, SCR, Sodero Gestion, BNP Paribas Développement SA, SCR, SMA Group Limited, Financiere Vertavienne 44 CI
More news
1 day-3.99%
1 week-3.76%
Current month-8.30%
1 month-7.05%
3 months+4.34%
6 months-17.04%
Current year+1.74%
More quotes
1 week
18.76
Extreme 18.76
21.30
1 month
18.76
Extreme 18.76
23.80
Current year
18.14
Extreme 18.14
23.80
1 year
16.92
Extreme 16.92
34.00
3 years
16.92
Extreme 16.92
58.80
5 years
16.92
Extreme 16.92
58.80
10 years
15.78
Extreme 15.78
68.60
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 98-12-31
Founder 73 89-12-31
Director of Finance/CFO 51 06-05-31
Members of the board TitleAgeSince
Founder 73 89-12-31
Chief Executive Officer 50 98-12-31
Director/Board Member 67 21-12-14
More insiders
Date Price Change Volume
24-03-28 20.45 -3.99% 10,198
24-03-27 21.3 +6.93% 6,786
24-03-26 19.92 +1.63% 17,565
24-03-25 19.6 -4.16% 9,036
24-03-22 20.45 -1.68% 4,239

Real-time Euronext Paris, March 28, 2024 at 12:35 pm EDT

More quotes
LNA Santé specializes in operating and managing full-care facilities for dependent elderly persons. Net sales break down by activity as follows: - operation of medico-social and healthcare homes (93.4%): managed, at the end of 2022, 82 establishments (9,335 beds) broken down into living facilities with medical care for old people (45; 4,655 beds), follow-up care and rehabilitation clinics (18; 2,853 places), nursing homes (4 in Belgium; 555 beds), home hospitalization structures (9; 680 places), surgical facilities (2; 168 beds), psychiatric hospital (2; 299 beds) and rehabilitation facilities (2 in Poland; 125 beds); - real estate development (6.6%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
20.45 EUR
Average target price
32.5 EUR
Spread / Average Target
+58.92%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock
  2. Equities
  3. Stock LNA Santé - Euronext Paris